Skip to main content
. 2016 Oct 25;155(1):22–31. doi: 10.1093/toxsci/kfw194

FIG. 3.

FIG. 3

Comprehensive in vitro proarrhythmia assay: 4 components. The goal is to develop a new in vitro paradigm for cardiac safety evaluation of new drugs that provides a more accurate and comprehensive mechanistic-based assessment of proarrhythmic potential.